Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for EWTX

Stock Name	Edgewise Therapeutics Inc
Ticker	EWTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US28036F1057

Show aggregate EWTX holdings

News associated with EWTX

JPMorgan Chase & Co. Lowers Edgewise Therapeutics (NASDAQ:EWTX) Price Target to $30.00: Edgewise Therapeutics (NASDAQ:EWTX – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $40.00 to $30.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an overweight rating on the stock. A number of other research analysts have also issued reports on EWTX. Royal Bank Of […] - 2025-08-20 03:02:43
TD Asset Management Inc Invests $730,000 in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): TD Asset Management Inc acquired a new position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 33,200 shares of the company’s stock, valued at approximately $730,000. Several other institutional investors also recently modified […] - 2025-08-05 04:37:18
Arizona State Retirement System Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Arizona State Retirement System raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,201 shares of the company’s stock after purchasing an additional 1,338 shares during the quarter. Arizona […] - 2025-07-23 05:44:46
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Arizona State Retirement System: Arizona State Retirement System boosted its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,201 shares of the company’s stock after acquiring an additional 1,338 shares during the period. Arizona […] - 2025-07-23 04:52:54
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Price Target at $40.00: Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the ten research firms that are presently covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 year […] - 2025-07-08 02:38:53
HC Wainwright Begins Coverage on Edgewise Therapeutics (NASDAQ:EWTX): HC Wainwright began coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) in a note issued to investors on Monday, MarketBeat reports. The firm set a “buy” rating and a $42.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 227.61% from the company’s previous close. Several […] - 2025-07-02 02:34:45
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $39.78 Consensus PT from Brokerages: Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokers […] - 2025-06-13 02:14:54
Squarepoint Ops LLC Purchases 9,729 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Squarepoint Ops LLC lifted its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 26,358 shares of the company’s stock after buying an additional 9,729 shares during the quarter. Squarepoint Ops LLC’s […] - 2025-06-03 05:04:51
Two Sigma Investments LP Reduces Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Two Sigma Investments LP lowered its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 49.6% in the 4th quarter, HoldingsChannel reports. The fund owned 131,667 shares of the company’s stock after selling 129,791 shares during the period. Two Sigma Investments LP’s holdings in Edgewise Therapeutics were worth $3,516,000 at the end of the […] - 2025-05-30 05:27:09
Nuveen Asset Management LLC Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Nuveen Asset Management LLC raised its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 58.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 428,858 shares of the company’s stock after purchasing an additional 158,452 shares during the quarter. Nuveen Asset Management LLC’s holdings in Edgewise Therapeutics were worth $11,451,000 at […] - 2025-05-28 04:58:59
BNP Paribas Financial Markets Buys Shares of 33,082 Edgewise Therapeutics, Inc. (NASDAQ:EWTX): BNP Paribas Financial Markets purchased a new position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 33,082 shares of the company’s stock, valued at approximately $883,000. Several other large investors have also recently made changes to their positions in EWTX. First Light Asset Management […] - 2025-05-22 04:38:48
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Average Recommendation of “Moderate Buy” from Brokerages: Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12 month […] - 2025-05-16 02:58:59
The Manufacturers Life Insurance Company Has $1.07 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): The Manufacturers Life Insurance Company increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 4.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,170 shares of the company’s stock after purchasing an additional 1,760 shares during the period. The Manufacturers […] - 2025-05-14 04:46:53
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Bought by Price T Rowe Associates Inc. MD: Price T Rowe Associates Inc. MD boosted its stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 22.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 29,050 shares of the company’s stock after purchasing an additional 5,242 shares […] - 2025-05-12 05:18:50
Dimensional Fund Advisors LP Grows Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Dimensional Fund Advisors LP grew its stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 729,923 shares of the company’s stock after buying an additional 3,052 shares during […] - 2025-05-08 04:50:47
Envestnet Asset Management Inc. Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Envestnet Asset Management Inc. increased its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.0% in the 4th quarter, HoldingsChannel reports. The fund owned 14,678 shares of the company’s stock after purchasing an additional 3,561 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Edgewise Therapeutics were worth $392,000 at the end […] - 2025-05-06 04:24:53
Edgewise Therapeutics (NASDAQ:EWTX) Earns Buy Rating from Analysts at Guggenheim: Guggenheim initiated coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm set a “buy” rating and a $41.00 price target on the stock. Guggenheim’s price target suggests a potential upside of 145.80% from the stock’s current price. Other […] - 2025-05-02 05:02:53
Invesco Ltd. Sells 21,341 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Invesco Ltd. lowered its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 32.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 43,435 shares of the company’s stock after selling 21,341 shares during the quarter. Invesco Ltd.’s holdings in Edgewise Therapeutics were worth $1,160,000 as of its most recent […] - 2025-05-02 04:26:44
Marshall Wace LLP Sells 547,672 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Marshall Wace LLP reduced its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 94.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,893 shares of the company’s stock after selling 547,672 shares during the period. […] - 2025-05-01 05:43:00
Barclays PLC Has $3.57 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Barclays PLC grew its position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 12.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 133,657 shares of the company’s stock after purchasing an additional 14,307 shares during the quarter. Barclays PLC’s holdings in Edgewise Therapeutics were worth $3,568,000 at the end of the […] - 2025-04-29 05:08:56
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $40.38 Average PT from Brokerages: Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month […] - 2025-04-24 02:10:55
Edgewise Therapeutics (NASDAQ:EWTX) Receives “Outperform” Rating from Wedbush: Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $43.00 price objective on the stock. Wedbush’s price target points to a potential upside of 217.81% from the company’s previous close. Several other research […] - 2025-04-23 03:00:59
Alliancebernstein L.P. Raises Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Alliancebernstein L.P. increased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,260 shares of the company’s stock after purchasing an additional 1,300 shares during the period. Alliancebernstein L.P.’s holdings […] - 2025-04-17 04:30:59
Geode Capital Management LLC Increases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Geode Capital Management LLC grew its holdings in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 0.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,600,571 shares of the company’s stock after purchasing an additional 1,036 shares during the quarter. Geode […] - 2025-04-15 05:08:57
Orion Portfolio Solutions LLC Decreases Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Orion Portfolio Solutions LLC decreased its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 8.3% during the 4th quarter, Holdings Channel.com reports. The fund owned 11,928 shares of the company’s stock after selling 1,083 shares during the period. Orion Portfolio Solutions LLC’s holdings in Edgewise Therapeutics were worth $318,000 at the […] - 2025-04-10 05:38:57
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Director Acquires $10,000,000.23 in Stock: Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) Director Orbimed Advisors Llc acquired 496,771 shares of Edgewise Therapeutics stock in a transaction that occurred on Thursday, April 3rd. The stock was acquired at an average price of $20.13 per share, with a total value of $10,000,000.23. Following the completion of the acquisition, the director now […] - 2025-04-07 06:28:50
Scotiabank Downgrades Edgewise Therapeutics (NASDAQ:EWTX) to Sector Perform: Edgewise Therapeutics (NASDAQ:EWTX – Get Free Report) was downgraded by research analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating in a research report issued on Wednesday, Marketbeat.com reports. They currently have a $14.00 target price on the stock, down from their prior target price of $50.00. Scotiabank’s price target would […] - 2025-04-04 03:14:47
Noteworthy Wednesday Option Activity: EWTX, PACK, ORCL: Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Edgewise Therapeutics Inc (Symbol: EWTX), where a total of 15,988 contracts have traded so far, representing approximately 1.6 million underlying shares. That amounts to - 2025-04-02 16:27:28
Teacher Retirement System of Texas Has $298,000 Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Teacher Retirement System of Texas raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) by 18.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,143 shares of the company’s stock after purchasing an […] - 2025-04-02 04:42:47
Quantbot Technologies LP Purchases Shares of 3,855 Edgewise Therapeutics, Inc. (NASDAQ:EWTX): Quantbot Technologies LP purchased a new stake in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 3,855 shares of the company’s stock, valued at approximately $103,000. Other institutional investors have also recently made changes to their positions […] - 2025-04-01 04:54:48

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) EWTX holdings

Date	Number of EWTX Shares Held	Base Market Value of EWTX Shares	Local Market Value of EWTX Shares	Change in EWTX Shares Held	Change in EWTX Base Value	Current Price per EWTX Share Held	Previous Price per EWTX Share Held
2025-11-12 (Wednesday)	67,800	USD 1,435,326	USD 1,435,326	174	USD -17,280	USD 21.17	USD 21.48
2025-11-11 (Tuesday)	67,626	USD 1,452,606	USD 1,452,606	0	USD 216,403	USD 21.48	USD 18.28
2025-11-10 (Monday)	67,626	USD 1,236,203	USD 1,236,203	173	USD 78,710	USD 18.28	USD 17.16
2025-11-07 (Friday)	67,453	USD 1,157,493	USD 1,157,493	0	USD 4,721	USD 17.16	USD 17.09
2025-11-06 (Thursday)	67,453	USD 1,152,772	USD 1,152,772	173	USD -15,882	USD 17.09	USD 17.37
2025-11-05 (Wednesday)	67,280	USD 1,168,654	USD 1,168,654	0	USD 3,028	USD 17.37	USD 17.325
2025-11-04 (Tuesday)	67,280	USD 1,165,626	USD 1,165,626	174	USD -40,269	USD 17.325	USD 17.97
2025-11-03 (Monday)	67,106	USD 1,205,895	USD 1,205,895	0	USD -20,803	USD 17.97	USD 18.28
2025-10-31 (Friday)	67,106	USD 1,226,698	USD 1,226,698	0	USD -26,171	USD 18.28	USD 18.67
2025-10-30 (Thursday)	67,106	USD 1,252,869	USD 1,252,869	870	USD 171,235	USD 18.67	USD 16.33
2025-10-29 (Wednesday)	66,236	USD 1,081,634	USD 1,081,634	348	USD -247	USD 16.33	USD 16.42
2025-10-28 (Tuesday)	65,888	USD 1,081,881	USD 1,081,881	0	USD 25,696	USD 16.42	USD 16.03
2025-10-27 (Monday)	65,888	USD 1,056,185	USD 1,056,185	0	USD 56,005	USD 16.03	USD 15.18

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of EWTX by Blackrock for IE00BDZVHG35

Show aggregate share trades of EWTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 BUY 174 21.570 20.340 20.463 USD 3,561 21.08
2025-11-10 BUY 173 18.700 16.975 17.148 USD 2,967 21.10
2025-11-06 BUY 173 18.260 17.070 17.189 USD 2,974 21.14
2025-11-04 BUY 174 17.885 16.990 17.079 USD 2,972 21.18
2025-10-30 BUY 870 18.800 16.330 16.577 USD 14,422 21.23
2025-10-29 BUY 348 16.330 16.744 16.703 USD 5,813 21.26
2025-10-22 SELL -696 14.890 15.642 15.567 USD -10,834 21.42 Profit of 4,075 on sale
2025-10-20 BUY 348 15.390 16.080 16.011 USD 5,572 21.49
2025-10-17 BUY 869 15.060 15.395 15.362 USD 13,349 21.53
2025-10-15 BUY 1,384 15.620 15.810 15.791 USD 21,855 21.56
2025-10-03 BUY 1,218 15.650 15.840 15.821 USD 19,270 21.64
2025-10-02 BUY 174 15.000 15.620 15.558 USD 2,707 21.68
2025-09-30 BUY 348 16.220 16.370 16.355 USD 5,692 21.75
2025-09-26 BUY 348 16.050 16.530 16.482 USD 5,736 21.82
2025-09-25 BUY 348 14.885 16.340 16.195 USD 5,636 21.87
2025-09-18 BUY 182 15.530 15.680 15.665 USD 2,851 21.91
2025-09-17 BUY 546 13.890 14.425 14.372 USD 7,847 21.96
2025-07-17 SELL -360 13.730 14.080 14.045 USD -5,056 22.17 Profit of 2,925 on sale
2025-07-11 SELL -1,448 13.840 13.870 13.867 USD -20,079 22.40 Profit of 12,349 on sale
2025-07-02 BUY 9,955 13.010 13.370 13.334 USD 132,740 22.64
2025-06-25 BUY 362 14.330 14.780 14.735 USD 5,334 22.90
2025-06-20 BUY 6,268 14.300 14.655 14.619 USD 91,635 23.08
2025-06-11 BUY 320 15.750 16.300 16.245 USD 5,198 23.51
2025-06-10 BUY 320 15.450 15.740 15.711 USD 5,028 23.57
2025-06-04 SELL -160 14.490 15.000 14.949 USD -2,392 23.84 Profit of 1,422 on sale
2025-04-23 BUY 160 14.830 14.940 14.929 USD 2,389 26.56
2025-04-10 SELL -1,272 11.570 12.250 12.182 USD -15,496 27.96 Profit of 20,064 on sale
2025-04-08 SELL -159 11.490 12.350 12.264 USD -1,950 28.32 Profit of 2,553 on sale
2025-04-07 SELL -160 11.830 12.100 12.073 USD -1,932 28.51 Profit of 2,631 on sale
2025-04-04 SELL -800 11.510 13.280 13.103 USD -10,482 28.71 Profit of 12,489 on sale
2025-04-01 BUY 1,687 20.130 22.470 22.236 USD 37,512 28.98
2025-03-31 SELL -468 22.000 23.120 23.008 USD -10,768 29.06 Profit of 2,833 on sale
2025-03-21 BUY 2,030 23.610 24.170 24.114 USD 48,951 29.53
2025-03-14 SELL -2,384 25.670 26.140 26.093 USD -62,206 29.82 Profit of 8,888 on sale
2025-03-07 SELL -298 28.010 30.040 29.837 USD -8,891 30.06 Profit of 66 on sale
2025-03-04 SELL -149 24.500 25.860 25.724 USD -3,833 30.23 Profit of 672 on sale
2025-02-25 BUY 298 25.080 25.380 25.350 USD 7,554 30.62
2025-02-19 SELL -149 26.670 27.000 26.967 USD -4,018 30.93 Profit of 590 on sale
2025-02-13 BUY 447 26.020 26.470 26.425 USD 11,812 31.34
2025-02-12 BUY 149 25.850 26.430 26.372 USD 3,929 31.45
2025-02-11 BUY 596 26.160 26.300 26.286 USD 15,666 31.56
2024-12-30 SELL -4,874 27.055 28.345 28.216 USD -137,525 33.22 Profit of 24,413 on sale
2024-11-18 SELL -2,415 30.790 31.180 31.141 USD -75,206 34.82 Profit of 8,883 on sale
2024-11-08 SELL -161 36.380 36.700 36.668 USD -5,904 34.68 Loss of -320 on sale
2024-10-21 SELL -162 34.850 35.565 35.493 USD -5,750 0.00 Loss of -5,750 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	BUY	174	21.570	20.340	20.463	USD 3,561	21.08
2025-11-10	BUY	173	18.700	16.975	17.148	USD 2,967	21.10
2025-11-06	BUY	173	18.260	17.070	17.189	USD 2,974	21.14
2025-11-04	BUY	174	17.885	16.990	17.079	USD 2,972	21.18
2025-10-30	BUY	870	18.800	16.330	16.577	USD 14,422	21.23
2025-10-29	BUY	348	16.330	16.744	16.703	USD 5,813	21.26
2025-10-22	SELL	-696	14.890	15.642	15.567	USD -10,834	21.42 Profit of 4,075 on sale
2025-10-20	BUY	348	15.390	16.080	16.011	USD 5,572	21.49
2025-10-17	BUY	869	15.060	15.395	15.362	USD 13,349	21.53
2025-10-15	BUY	1,384	15.620	15.810	15.791	USD 21,855	21.56
2025-10-03	BUY	1,218	15.650	15.840	15.821	USD 19,270	21.64
2025-10-02	BUY	174	15.000	15.620	15.558	USD 2,707	21.68
2025-09-30	BUY	348	16.220	16.370	16.355	USD 5,692	21.75
2025-09-26	BUY	348	16.050	16.530	16.482	USD 5,736	21.82
2025-09-25	BUY	348	14.885	16.340	16.195	USD 5,636	21.87
2025-09-18	BUY	182	15.530	15.680	15.665	USD 2,851	21.91
2025-09-17	BUY	546	13.890	14.425	14.372	USD 7,847	21.96
2025-07-17	SELL	-360	13.730	14.080	14.045	USD -5,056	22.17 Profit of 2,925 on sale
2025-07-11	SELL	-1,448	13.840	13.870	13.867	USD -20,079	22.40 Profit of 12,349 on sale
2025-07-02	BUY	9,955	13.010	13.370	13.334	USD 132,740	22.64
2025-06-25	BUY	362	14.330	14.780	14.735	USD 5,334	22.90
2025-06-20	BUY	6,268	14.300	14.655	14.619	USD 91,635	23.08
2025-06-11	BUY	320	15.750	16.300	16.245	USD 5,198	23.51
2025-06-10	BUY	320	15.450	15.740	15.711	USD 5,028	23.57
2025-06-04	SELL	-160	14.490	15.000	14.949	USD -2,392	23.84 Profit of 1,422 on sale
2025-04-23	BUY	160	14.830	14.940	14.929	USD 2,389	26.56
2025-04-10	SELL	-1,272	11.570	12.250	12.182	USD -15,496	27.96 Profit of 20,064 on sale
2025-04-08	SELL	-159	11.490	12.350	12.264	USD -1,950	28.32 Profit of 2,553 on sale
2025-04-07	SELL	-160	11.830	12.100	12.073	USD -1,932	28.51 Profit of 2,631 on sale
2025-04-04	SELL	-800	11.510	13.280	13.103	USD -10,482	28.71 Profit of 12,489 on sale
2025-04-01	BUY	1,687	20.130	22.470	22.236	USD 37,512	28.98
2025-03-31	SELL	-468	22.000	23.120	23.008	USD -10,768	29.06 Profit of 2,833 on sale
2025-03-21	BUY	2,030	23.610	24.170	24.114	USD 48,951	29.53
2025-03-14	SELL	-2,384	25.670	26.140	26.093	USD -62,206	29.82 Profit of 8,888 on sale
2025-03-07	SELL	-298	28.010	30.040	29.837	USD -8,891	30.06 Profit of 66 on sale
2025-03-04	SELL	-149	24.500	25.860	25.724	USD -3,833	30.23 Profit of 672 on sale
2025-02-25	BUY	298	25.080	25.380	25.350	USD 7,554	30.62
2025-02-19	SELL	-149	26.670	27.000	26.967	USD -4,018	30.93 Profit of 590 on sale
2025-02-13	BUY	447	26.020	26.470	26.425	USD 11,812	31.34
2025-02-12	BUY	149	25.850	26.430	26.372	USD 3,929	31.45
2025-02-11	BUY	596	26.160	26.300	26.286	USD 15,666	31.56
2024-12-30	SELL	-4,874	27.055	28.345	28.216	USD -137,525	33.22 Profit of 24,413 on sale
2024-11-18	SELL	-2,415	30.790	31.180	31.141	USD -75,206	34.82 Profit of 8,883 on sale
2024-11-08	SELL	-161	36.380	36.700	36.668	USD -5,904	34.68 Loss of -320 on sale
2024-10-21	SELL	-162	34.850	35.565	35.493	USD -5,750	0.00 Loss of -5,750 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of EWTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	151,138	0	266,759	56.7%
2025-09-18	299,086	3,699	715,954	41.8%
2025-09-17	85,673	0	187,067	45.8%
2025-09-16	107,267	0	205,730	52.1%
2025-09-15	103,285	8,072	172,990	59.7%
2025-09-12	110,533	0	154,794	71.4%
2025-09-11	210,979	9,705	313,841	67.2%
2025-09-10	83,057	286	215,101	38.6%
2025-09-09	136,813	0	242,643	56.4%
2025-09-08	178,475	800	250,273	71.3%
2025-09-05	125,435	0	296,399	42.3%
2025-09-04	110,435	0	200,421	55.1%
2025-09-03	285,589	0	509,995	56.0%
2025-09-02	138,507	0	509,980	27.2%
2025-08-29	122,360	0	254,036	48.2%
2025-08-28	739,852	0	812,279	91.1%
2025-08-27	113,992	0	277,828	41.0%
2025-08-26	600,110	0	1,695,669	35.4%
2025-08-25	147,428	0	175,881	83.8%
2025-08-22	97,199	3,000	158,897	61.2%
2025-08-21	186,801	8,916	288,590	64.7%
2025-08-20	90,423	0	112,060	80.7%
2025-08-19	168,400	0	225,305	74.7%
2025-08-18	101,427	0	142,646	71.1%
2025-08-15	71,678	0	132,129	54.2%
2025-08-14	65,874	0	119,449	55.1%
2025-08-13	65,071	0	242,949	26.8%
2025-08-12	120,620	35,365	504,422	23.9%
2025-08-11	112,383	0	165,886	67.7%
2025-08-08	88,220	0	182,998	48.2%
2025-08-07	129,711	292	209,605	61.9%
2025-08-06	91,202	14	145,015	62.9%
2025-08-05	117,358	0	203,709	57.6%
2025-08-04	133,556	0	351,254	38.0%
2025-08-01	168,174	2,682	212,557	79.1%
2025-07-31	127,977	0	171,129	74.8%
2025-07-30	228,806	275	441,915	51.8%
2025-07-29	118,810	1,021	226,399	52.5%
2025-07-28	95,917	0	204,807	46.8%
2025-07-25	173,852	0	257,272	67.6%
2025-07-24	88,412	28	140,898	62.7%
2025-07-23	86,436	24	217,266	39.8%
2025-07-22	53,712	0	75,171	71.5%
2025-07-21	44,608	0	73,911	60.4%
2025-07-18	64,350	0	89,878	71.6%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE